Afatinib

Afatinib is a targeted cancer medication used primarily to treat certain types of non-small cell lung cancer. It works by blocking specific proteins called EGFR and HER2 that help cancer cells grow and divide. By inhibiting these proteins, Afatinib can slow or stop the progression of the cancer. It is usually taken orally as a pill and is prescribed under medical supervision. While effective for some patients, it may cause side effects such as diarrhea, rash, or fatigue. Afatinib represents a personalized approach to cancer treatment, targeting molecules involved in tumor growth.